Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00456326 · ClinicalTrials.gov registry record
Heparin-Induced Thrombocytopenia Registry
A clinical trial, sponsored by Brigham and Women's Hospital.
- Completed
- Registry status
- 242
- Enrollment target
NCT00456326 is a clinical trial that has completed, run by Brigham and Women's Hospital. The registered enrollment target is 242 participants.
The verdict
NCT00456326 has completed, sponsored by Brigham and Women's Hospital.
- COMPLETED
- Registry status
- 242 participants
- Enrollment target
Study Summary
The purpose of the Heparin Induced Thrombocytopenia Registry is to explore the frequency of heparin-induced thrombocytopenia (HIT) at Brigham and Women's Hospital and to assess its mortality rate. Retrospective 3 years, looking forward prospectively.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 242 participants |
| Start Date | 2005-10 |
| Est. Completion | 2007-08 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00456326
The ClinicalTrials.gov registry entry for NCT00456326 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 242 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Brigham and Women's Hospital, which has 937 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00456326 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00456326 about?
NCT00456326 is a clinical study titled "Heparin-Induced Thrombocytopenia Registry". The purpose of the Heparin Induced Thrombocytopenia Registry is to explore the frequency of heparin-induced thrombocytopenia (HIT) at Brigham and Women's Hospital and to assess its mortality rate. Retrospective 3 years, looking forward prospectively.
What is the current status of trial NCT00456326?
This trial is currently completed. The enrollment target is 242 participants. The study started on 2005-10. Estimated completion is 2007-08.
Who is sponsoring clinical trial NCT00456326?
This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.